News
- 2026/03/24
- Mie Television featured Noile-Immune Biotech in the “Insight Monthly”, a corner of “Okasan Investment Navi” as a “company aiming to overcome cancer through the immune system” (Information updated on April 2, 2026).
- ---------------------------------------------------
“Okasan Investment Navi”, Mie Television Broadcasting Co., Ltd.- Episode 1: Aired on March 7, 2026
- Episode 2: Aired on March 14, 2026
- Episode 3: Aired on March 21, 2026
- Episode 4: Aired on March 28, 2026
---------------------------------------------------
- 2026/03/23
- Seminar Presentation at 25th Annual Meeting of the Japanese Society for Regenerative Medicine as Co-sponsored Scientific Seminar
We are pleased to announce that Dr. Koji Tamada, President and CEO of our company (Professor, Department of Immunology, Yamaguchi University Graduate School of Medicine; Director, Research Institute for Cell Design Medical Science), served as the session chair, and Dr. Akihiko Yoshimura, Professor in the Division of Molecular Pathology, Research Institute for Biomedical Sciences, Tokyo University of Science and also an advisor to our company, delivered a presentation on advances in CAR-T cell technology at the Co-sponsored Scientific Seminar (Luncheon Seminar 20, co-sponsored by Hitachi, Ltd.) held during the 25th Annual Meeting of the Japanese Society for Regenerative Medicine (March 19–20, 2026, Kobe International Conference Center and Kobe International Exhibition Hall).
- Conference: The 25th Annual Meeting of the Japanese Society for Regenerative Medicine (March 19–20, 2026; Kobe International Conference Center and Kobe International Exhibition Hall, Kobe, Japan)
- Date and time： March 20, 2026 (Friday), 12:00～12:50
- Session：Frontiers in Immunotherapy
- Chair：Koji Tamada, MD, Ph.D. (Professor, Department of Immunology, Yamaguchi University Graduate School of Medicine / Director, Research Institute for Cell Design Medical Science, Yamaguchi University)
- Presentation Title: T cell exhaustion and stem cell-like memory T cells: Novel strategies to enhance antitumor immunity
- Speaker: Akihiko Yoshimura, Ph.D. (Professor, Division of Molecular Pathology, Research Institute for Biomedical Sciences, Tokyo University of Science)
- 2026/03/16
- Noile-Immune has been awarded the FY2025 Foreign Patent Application Cost Subsidy Program.
- The details is shown here>
- 2026/02/10
- Noile-Immune Biotech Inc. has elucidated the mechanism by which PRIME CAR-T cells demonstrate superior therapeutic effects against solid cancers through collaborative research with the Department of Immunology, Yamaguchi University Graduate School of Medicine and hereby announces that these findings have been published in Cancer Immunology, Immunotherapy.
- The details is shown here>